Parkinson disease-associated cognitive impairment
Open accessThe DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–291 of 291
de Roos, P., Bloem, B. R., Kelley, T. A., Antonini, A., Dodel, R. C., Hagell, P., Marras, C., Martínez‐Martín, P., Mehta, S. H., Odin, P., et al. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-161055 · Cited by 73
Self-citationPurri, R., Brennan, L., Rick, J. H., Xie, S. X., Deck, B. L., Chahine, L. M., Dahodwala, N. A., Chen‐Plotkin, A. S., Duda, J. E., Morley, J. F., et al. (2020) · Movement Disorders · doi:10.1002/mds.28115 · Cited by 73
Self-citationParkinson's Disease and Post–COVID ‐19 Syndrome: The Parkinson's Long‐COVID Spectrum
Leta, V., Rodríguez‐Violante, M., Abundes‐Corona, A., Rukavina, K., Teo, J., Falup‐Pecurariu, C., Irincu, L., Rota, S., Bhidayasiri, R., Storch, A., et al. (2021) · Movement Disorders · doi:10.1002/mds.28622 · Cited by 73
Arguing against the proposed definition changes of PD
Boeve, B. F., Dickson, D. W., Duda, J. E., Ferman, T. J., Galasko, D. R., Galvin, J. E., Goldman, J. G., Growdon, J. H., Hurtig, H. I., Kaufer, D. I., et al. (2016) · Movement Disorders · doi:10.1002/mds.26721 · Cited by 72
Self-citationDementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
Friedman, J. H. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.013 · Cited by 72
Cognition in Rapid Eye Movement Sleep Behavior Disorder
Gagnon, J., Bertrand, J., & Marchand, D. G. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00082 · Cited by 71
Obstructive Sleep Apnea and Cognition in Parkinson's disease
Harmell, A. L., Neikrug, A. B., Palmer, B. W., Avanzino, J. A., Liu, L., Maglione, J. E., Natarajan, L., Corey‐Bloom, J., Loredo, J. S., & Ancoli‐Israel, S. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.01.001 · Cited by 71
Liu, A. K. L., Chau, T. W., Lim, E., Ahmed, I., Chang, R. C., Kalaitzakis, M. E., Graeber, M. B., Gentleman, S., & Pearce, R. K. B. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0717-3 · Cited by 69
Device-Aided Treatment Strategies in Advanced Parkinson's Disease
Timpka, J., Nitu, B., Датиева, В. К., Odin, P., & Antonini, A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.03.001 · Cited by 67
Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease
Chahine, L. M., dos Santos, C. L., Fullard, M. E., Scordia, C., Weintraub, D. A., Erus, G., Rosenthal, L. S., Davatzikos, C. A., & McMillan, C. T. (2018) · European Journal of Neurology · doi:10.1111/ene.13797 · Cited by 67
Self-citationPatterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease
Mantri, S., Fullard, M. E., Gray, S. L., Weintraub, D. A., Hubbard, R. A., Hennessy, S., & Willis, A. W. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2820 · Cited by 67
Self-citationPerez, F., Helmer, C., Foubert‐Samier, A., Auriacombe, S., Dartigues, J., & Tison, F. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.230 · Cited by 66
Risk of Parkinson's disease dementia related to level I MDS PD‐MCI
Hoogland, J., Boel, J. A., de Bie, R. M. A., Schmand, B. A., Geskus, R. B., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Weintraub, D. A., Junqué, C., et al. (2019) · Movement Disorders · doi:10.1002/mds.27617 · Cited by 66
Self-citationPlasma NfL, clinical subtypes and motor progression in Parkinson's disease
Pilotto, A., Imarisio, A., Conforti, F., Scalvini, A., Masciocchi, S., Nocivelli, S., Turrone, R., Gipponi, S., Cottini, E., Borroni, B., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.04.016 · Cited by 66
Morley, D., Dummett, S., Peters, M., Kelly, L., Hewitson, P., Dawson, J., Fitzpatrick, R. M., & Jenkinson, C. (2012) · Parkinson s Disease · doi:10.1155/2012/190901 · Cited by 65
Jones, J. D., Kuhn, T. P., & Szymkowicz, S. M. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.12.006 · Cited by 65
Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
Sasikumar, S., & Strafella, A. P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00047 · Cited by 65
Serotonin, β‐amyloid, and cognition in Parkinson disease
Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R., & Albin, R. L. (2018) · Annals of Neurology · doi:10.1002/ana.25236 · Cited by 64
Non-invasive brain stimulation in Parkinson’s disease: Exploiting crossroads of cognition and mood
Dinkelbach, L., Brambilla, M., Manenti, R., & Brem, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.021 · Cited by 63
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?
Biundo, R., Weis, L., Fiorenzato, E., & Antonini, A. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx092 · Cited by 63
Νούσια, Α., Μαρτζούκου, Μ., Tsouris, Z., Siokas, V., Aloizou, A., Liampas, I., Nasios, G., & Dardiotis, E. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz080 · Cited by 63
Why are neuropsychologists so reluctant to embrace modern assessment techniques?
Schmand, B. A. (2019) · The Clinical Neuropsychologist · doi:10.1080/13854046.2018.1523468 · Cited by 60
Rare Variants in Specific Lysosomal Genes Are Associated With Parkinson's Disease
Hopfner, F., Mueller, S. H., Szymczak, S., Junge, O., Tittmann, L., May, S., Lohmann, K., Grallert, H., Lieb, W., Strauch, K., et al. (2020) · Movement Disorders · doi:10.1002/mds.28037 · Cited by 60
Chung, S. J., Yoo, H. S., Lee, Y. H., Lee, H. S., Ye, B. S., Sohn, Y. H., Kwon, H., & Lee, P. H. (2019) · Human Brain Mapping · doi:10.1002/hbm.24631 · Cited by 59
Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19
Owens, A. P., Ballard, C. G., Beigi, M., Kalafatis, C., Brooker, H. J., Lavelle, G., Brønnick, K., Sauer, J., Boddington, S., Velayudhan, L., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.579934 · Cited by 59
Self-citationMultivariate prediction of dementia in Parkinson’s disease
Phongpreecha, T., Cholerton, B., Mata, I. F., Zabetian, C. P., Poston, K. L., Aghaeepour, N., Tian, L., Quinn, J. F., Chung, K. A., Hiller, A., et al. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-00121-2 · Cited by 58
Abolishing the 1‐year rule: How much evidence will be enough?
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Marek, K., Litvan, I., Lang, A. E., Halliday, G., et al. (2016) · Movement Disorders · doi:10.1002/mds.26796 · Cited by 56
Self-citationPetrova, M., Mehrabian-Spasova, S., Aarsland, D., Raycheva, M. R., & Traykov, L. D. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000375363 · Cited by 55
Self-citationStuckenschneider, T., Askew, C. D., Menêses, A. L., Baake, R., Weber, J., & Schneider, S. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-181484 · Cited by 55
FLAME: A computerized neuropsychological composite for trials in early dementia
Brooker, H. J., Williams, G. H., Hampshire, A., Corbett, A., Aarsland, D., Cummings, J. L., Molinuevo, J. L., Atri, A., Ismail, Z., Creese, B., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12098 · Cited by 55
Self-citationA Prodromal Brain‐Clinical Pattern of Cognition in Synucleinopathies
Rahayel, S., Postuma, R. B., Montplaisir, J. Y., Mišić, B., Tremblay, C., Vo, A., Lewis, S. J. G., Matar, E., Martens, K. A. E., Blanc, F., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25962 · Cited by 55
Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
Hung, A. Y., & Schwarzschild, M. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00964-w · Cited by 54
Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease
Longardner, K., Bayram, E., & Litvan, I. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00897 · Cited by 53
Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s Disease with Mild Cognitive Impairment
Jia, X., Wang, Z., Yang, T., Li, Y., Gao, S., Wu, G., Jiang, T., & Liang, P. (2018) · Aging and Disease · doi:10.14336/ad.2018.1116 · Cited by 52
Doping the Mind: Dopaminergic Modulation of Prefrontal Cortical Cognition
Ranganath, A., & Jacob, S. N. (2016) · The Neuroscientist · doi:10.1177/1073858415602850 · Cited by 50
Factor analysis–derived cognitive profile predicting early dementia conversion in PD
Chung, S. J., Lee, H. S., Kim, H.-R., Yoo, H. S., Lee, Y. H., Jung, J. H., Baik, K., Ye, B. S., Sohn, Y. H., & Lee, P. H. (2020) · Neurology · doi:10.1212/wnl.0000000000010347 · Cited by 50
Association of amyloid-β CSF/PET discordance and tau load 5 years later
Reimand, J., Collij, L., Scheltens, P., Bouwman, F., Ossenkoppele, R., & Initiative, F. T. A. D. N. (2020) · Neurology · doi:10.1212/wnl.0000000000010739 · Cited by 50
Parkinson's Disease Research on the African Continent: Obstacles and Opportunities
Dekker, M. C. J., Coulibaly, T., Bardien, S., Ross, O. A., Carr, J. A., & Komolafe, M. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00512 · Cited by 49
Sawada, H., Oeda, T., Kohsaka, M., Umemura, A., Tomita, S., Park, K., Mizoguchi, K., Matsuo, H., Hasegawa, K., Fujimura, H., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318107 · Cited by 48
Phillips, N. A., Chertkow, H. M., Pichora-Fuller, M. K., & Wittich, W. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16469 · Cited by 48
Howard, E., Irwin, D. J., Rascovsky, K., Nevler, N., Shellikeri, S., Tropea, T. F., Spindler, M., Deik, A., Chen-Plotkin, A., Siderowf, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011699 · Cited by 47
Self-citationPredicting Individual Preferences in Mindfulness Techniques Using Personality Traits
Tang, R., & Braver, T. S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01163 · Cited by 47
Multidimensional care burden in Parkinson-related dementia
Vatter, S., McDonald, K. R., Stanmore, E., Clare, L., & Leroi, I. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718802104 · Cited by 46
A Randomized Clinical Trial of Atomoxetine for Mild Cognitive Impairment in Parkinson's Disease
Hinson, V. K., Delambo, A., Elm, J. J., & Turner, T. H. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12455 · Cited by 45
Cognition among individuals along a spectrum of increased risk for Parkinson’s disease
Chahine, L. M., Urbe, L., Caspell‐Garcia, C., Aarsland, D., Alcalay, R. N., Barone, P., Burn, D. J., Espay, A. J., Hamilton, J. L., Hawkins, K. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201964 · Cited by 44
Self-citationVatter, S., Stanmore, E., Clare, L., McDonald, K. R., McCormick, S. A., & Leroi, I. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719853043 · Cited by 44
Mapping Cortical Atrophy in Parkinson's Disease Patients with Dementia
Hwang, K., Beyer, M. K., Green, A. E., Chung, C., Thompson, P. M., Janvin, C. C., Larsen, J. O., Aarsland, D., & Apostolova, L. G. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120151 · Cited by 43
Self-citationDopamine Promotes Cognitive Effort by Biasing the Benefits Versus Costs of Cognitive Work
Westbrook, A., van den Bosch, R., Määttä, J. I., Hofmans, L., Papadopetraki, D., Cools, R., & Frank, M. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/778134 · Cited by 41
Pillet, L., Taccola, C., Cotoni, J., Thiriez, H., André, K., & Verpillot, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0841-7 · Cited by 41
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease
Johar, I., Mollenhauer, B., & Aarsland, D. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2016.12.001 · Cited by 39
Self-citationEvaluation of an ontology-based system for computerized cognitive rehabilitation
Alloni, A., Quaglini, S., Panzarasa, S., Sinforiani, E., & Bernini, S. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.04.005 · Cited by 39
D’Souza, T., & Rajkumar, A. P. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.28 · Cited by 39
Mo, J., Liu, L.-Y., Peng, W.-B., Rao, J., Liu, Z., & Cui, L. (2017) · BMC Neurology · doi:10.1186/s12883-017-0885-3 · Cited by 36
Utility of quantitative EEG in early Lewy body disease
Massa, F., Meli, R., Grazzini, M., Famà, F., De Carli, F., Filippi, L., Arnaldi, D., Pardini, M., Morbelli, S., & Nobili, F. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.05.007 · Cited by 35
Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment
Chandler, J. M., Nair, R., Biglan, K., Ferries, E. A., Munsie, L. M., Changamire, T., & Patel, N. C. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202190 · Cited by 35
Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease
Bäckström, D. C., Domellöf, M., Granåsen, G., Linder, J., Mayans, S., Elgh, E., Zetterberg, H., Blennow, K., & Forsgren, L. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12812 · Cited by 34
Tseng, E., Rowell, W. J., Glenn, O.-C., Hon, T., Barrera, J., Kujawa, S., & Chiba‐Falek, O. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00584 · Cited by 34
Green, H., Tsitsi, P., Markaki, I., Aarsland, D., & Svenningsson, P. (2019) · CNS Drugs · doi:10.1007/s40263-018-0601-x · Cited by 33
Self-citationOwens, A. P., Hinds, C., Manyakov, N. V., Stavropoulos, T. G., Lavelle, G., Gove, D., Diaz-Ponce, A. M., & Aarsland, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.582207 · Cited by 33
Self-citationTagliafierro, L., Glenn, O.-C., Zamora, M. E., Beach, T. G., Woltjer, R. L., Lutz, M. W., & Chiba‐Falek, O. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.03.001 · Cited by 32
Neuropathological Findings in Parkinson's Disease With Mild Cognitive Impairment
Knox, M. G., Adler, C. H., Shill, H. A., Driver‐Dunckley, E. D., Mehta, S. H., Belden, C. M., ZAMRINI, E. Y., Serrano, G. E., Sabbagh, M. N., Caviness, J. N., et al. (2020) · Movement Disorders · doi:10.1002/mds.27991 · Cited by 32
Jiang, Z., Huang, Y., Zhang, P., Han, C., Lu, Y., Mo, Z., Zhang, Z., Li, X., Zhao, S., Cai, F., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00637-x · Cited by 32
Mediating effect of mutuality on caregiver burden in Parkinson’s disease partners
Karlstedt, M., Fereshtehnejad, S., Aarsland, D., & Lökk, J. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1619165 · Cited by 30
Self-citationMandler, M., Rockenstein, E. M., Overk, C., Mante, M., Florio, J. B., Adame, A., Kim, C., Santic, R., Schneeberger, A., Mattner, F., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.002 · Cited by 30
Alexandris, A. S., Walker, L., Liu, A. K. L., McAleese, K. E., Johnson, M., Pearce, R. K. B., Gentleman, S., & Attems, J. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12577 · Cited by 30
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2022) · Columbia Academic Commons (Columbia University) · doi:10.7916/qbbr-9x61 · Cited by 30
“Current dementia care: what are the difficulties and how can we advance care globally?”
Giebel, C. M. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05307-1 · Cited by 29
Takamatsu, Y., Ho, G. J., Koike, W., Sugama, S., Takenouchi, T., Waragai, M., Wei, J., Sekiyama, K., & Hashimoto, M. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-016-0001-1 · Cited by 28
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
Nicastro, N., Garibotto, V., & Burkhard, P. R. (2020) · BMC Neurology · doi:10.1186/s12883-020-01777-2 · Cited by 28
Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson’s disease
Hurt, C. S., Rixon, L., Chaudhuri, К. R., Moss-Morris, R. E., Samuel, M., & Brown, R. G. (2016) · Journal of Health Psychology · doi:10.1177/1359105316683239 · Cited by 27
Cognitive deficits in Parkinson’s disease with excessive daytime sleepiness: a systematic review
Jester, D. J., Lee, S., Molinari, V., & Volicer, L. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1660852 · Cited by 27
Litvan, I., Kieburtz, K. D., Tröster, A. I., & Aarsland, D. (2018) · Movement Disorders · doi:10.1002/mds.27345 · Cited by 26
Self-citationPredicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Yousaf, T., Pagano, G., Niccolini, F., & Politis, M. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09250-y · Cited by 25
Common age‐related neuropathologies and yearly variability in cognition
Yu, L., Wang, T., Wilson, R. S., Leurgans, S. E., Schneider, J. A., Bennett, D. A., & Boyle, P. A. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50857 · Cited by 25
Impulse control and related behaviors in Parkinson’s disease with dementia
Martínez‐Martín, P., Wan, Y.-M., Chaudhuri, К. R., Schrag, A. E., & Weintraub, D. A. (2020) · European Journal of Neurology · doi:10.1111/ene.14169 · Cited by 25
Self-citationFrequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease
Abraham, D. S., Nguyen, T. P. P., Hennessy, S., Weintraub, D. A., Gray, S. L., Xie, D., & Willis, A. W. (2020) · Age and Ageing · doi:10.1093/ageing/afaa033 · Cited by 25
Self-citationMavroudis, I. A., Petridis, F., Chatzikonstantinou, S., & Kazis, D. A. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000381 · Cited by 25
The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease
Chahine, L. M., Edison, B., Daeschler, M., Mantri, S., Kahl, S., Rapoport, R., Goyle, A., Precht, C., Kopil, C., & Marras, C. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12915 · Cited by 24
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease
van der Zee, S., Vermeiren, Y., Fransén, E., Dam, D. V., Aerts, T., Gerritsen, M. J. J., Spikman, J. M., van Laar, T., & Deyn, P. P. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-171228 · Cited by 22
Parkinson's disease in the MENASA countries
Khalil, H. W., Chahine, L. M., Siddiqui, J., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30026-0 · Cited by 21
Pillet, L., Taccola, C., Cotoni, J., Thiriez, H., André, K., & Verpillot, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01102-y · Cited by 20
Roussotte, F. F., Gutman, B. A., Hibar, D. P., Madsen, S. K., Narr, K. L., Thompson, P. M., & (ADNI), A. D. N. I. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.011 · Cited by 19
Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study
Smith, C., Cullen, B., Sheridan, M. P., Cavanagh, J., Grosset, K. A., & Grosset, D. G. (2020) · Acta Neurologica Scandinavica · doi:10.1111/ane.13226 · Cited by 18
Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders
Sinn, D.-I., & Gibbons, C. H. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0410-9 · Cited by 17
Tau Tangles in Parkinson’s Disease: A 2-Year Follow-Up Flortaucipir PET Study
Hansen, A. K., Parbo, P., Ismail, R., Østergaard, K., Brooks, D. J., & Borghammer, P. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191774 · Cited by 17
Miranda, G. G., Rodrigue, K. M., & Kennedy, K. M. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.027 · Cited by 15
Kaiyrzhanov, R. B., Rizig, M., Aitkulova, A. M., Асановна, Ж. Н., Shashkin, C., Kaishibayeva, G., Karimova, A., Т.Н., Х., Sadykova, D., Ganieva, M. T., et al. (2019) · Parkinson s Disease · doi:10.1155/2019/2905739 · Cited by 14
Dopamine pathway gene variants may modulate cognitive performance in the DHS – Mind Study
Martelle, S. E., Raffield, L. M., Palmer, N. D., Cox, A. J., Freedman, B. I., Hugenschmidt, C. E., Williamson, J. D., & Bowden, D. W. (2016) · Brain and Behavior · doi:10.1002/brb3.446 · Cited by 11
Protein Misfolding Cyclic Amplification
Moda, F., Pritzkow, S., & Soto, C. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5305-5_6 · Cited by 10
Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability
Zhan, Y., Raza, M. U., Yuan, L., & Zhu, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.036 · Cited by 9
Gámez‐Valero, A., Canet-Pons, J., Urbizu, A., Anillo, A., dos Santos, C. M. P., Ariza, A., & Beyer, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180074 · Cited by 8
Cited by
Afzal, S., Abdul Manap, A. S., Attiq, A., Albokhadaim, I., Kandeel, M., & Alhojaily, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 416
Yen, C., Lin, C.-L., & Chiang, M.-C. (2023) · Life · doi:10.3390/life13071472 · Cited by 281
Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
Yu, J. E., Yeo, I. J., Han, S.-B., Yun, J., Kim, B., Yong, Y. J., Lim, Y.-S., Kim, T. H., Son, D. J., & Hong, J. T. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01131-9 · Cited by 109
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
“302,303 The primary clinical symptom of PD is motor impairment, in addition to non-motor de fi cits including cognitive decline, 304,305 depression, and pain, which greatly affect the quality of life of patients.”
Xie, Z., Zhang, M., Luo, Y., Jin, D., Guo, X., Yang, W., Zheng, J., Zhang, H., Zhang, L., Deng, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0309 · Cited by 80
“Parkinson’s disease (PD) is the second leading neurodegenerative disease in the world, impacting more than 1.5% of people aged over 65 years, and its prevalence is expected to double by 2030 [1].”
Influential
Metadata
- Authors
- Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D.
- Venue
- Nature Reviews Disease Primers
- Published
- 2021-07-01
- Volume
- 7
- Issue
- 1
- Pages
- 47-47
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W3174664487
- Cited by
- 1,371
- References
- 291
- FWCI
- 27.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.